Chapters, Booklets, Books and Proceedings

  1. Nouri AME, Oliver RTD, Nargund V. Clonal development of bladder cancer and its relevance to the Clinical potential of HLA antigen and p53 based gene therapy. In: Cancer Surveys in Bladder Cancer (Volume 31). Oliver RTD and Coptcoat M (Eds.): Imperial Cancer Research Fund, London (1998). 109-128
  2. Oliver RTD, Badenoch DF, Nargund V, Sohaib SA, Lane T, Ong J, Cullen M. Chemotherapy
    for testis conservation in patients with germ cell tumours: Is it safe and could combination
    with tumour enucleation increase the frequency of success? Germ Cell Tumours V:
    Proceedings of the 5th International Germ Cell Tumour Conference, University of Leeds.
    Springer UK 2001. Harnenden P, Joffe J and Jones J (Eds).
  3. Oliver RTD, Lane T, Wells P, Chinegwundoh FC, Nargund V H. Medical interventions
    relevant in prevention and management of early prostate Cancer: a new potential role for
    GPs, schools and works’ medical officers, as well as STD, family planning and infertility
    clinics. In: The Effecive Management of Prostate Cancer. Wallace DMA, Oliver RTD, Ash D
    and Miles A. Aesculapius Medical Press, London (2002) ISBN 1 903044 25 1 Soft back
  4. Booklet BACUP Series for Cancer Patients: Cancer of the kidney. July 2004
  5. Booklet BACUP Series for Cancer Patients: Testicular Cancer. December 2005, 2009
  6. Oliver RTD, Ong J, Berney D, Nargund V, Badenoch D, Shamash J. Testis conserving
    chemotherapy in germ cell cancer: Its potential to increase understanding of the biology and
    treatment of carcinoma in situ. In: Testicular Germ Cell Neoplasia: A Developmental
    Disease? Rajpert-De Meyts E, Grigor KM, Skakkabaek NE (Eds.). Blackwell, Munksgaard
    (2003); 86-92
  7. Ghani K and Nargund VH. Chapter 3: Haematuria and Haematospermia. In Urological
    Oncology Nargund V, Raghavan D and Sandler H M (Eds), Springer UK, London (2007); 107-
    121
  8. Oliver RTD, Shamash J, Nargund VH. Chapter 17.1 Testicular- Germ Cell Tumours. In
    Urological Oncology. Nargund V H, Raghavan D and Sandler H M(Eds), Springer UK, London
    (2007); 401-444
  9. Kumar P and Nargund V H. Urethral cancer (excluding penile cancer). In Urological
    Oncology by Nargund V H, Raghavan D and Sandler H (Eds), Springer UK, London (2007);
    390-400
  10. Nargund V H. Chapter 18.2. Clinical presentation, Diagnosis and Staging. In Urological
    Oncology by Nargund V H, Raghavan D and Sandler H (Eds), Springer UK, London (2007);
    470-481
  11. Nargund V. Chapter 18.3. Surgical Management of Cracinoma of Prostate. In Urological
    Oncology by Nargund V H, Raghavan D and Sandler H M (Eds), Springer UK, London
    (2007); 482-496
  12. Oliver RTD, Powles T, Nargund V, Berney D Chapter 22: Spontaneous Regression of
    Renal Cell Cancer and the Role of Prognostic Factors. In Clinical Management of Renal
    Tumours: Bukowski R M, Novick A (Eds.) 2008, 665 p. 174 illus., Hardcover; ISBN: 978-1-
    58829-251-3 Humana Press (Publisher)
  13. Klinefelter Syndrome Association UK Literature: V. Nargund- Orchidectomy, Testicular Cancer and Testicular Prosthesis 2007
  14. Book Editorship: Urological Oncology – Vinod H Nargund (London UK), Derek Raghavan (Cleveland, USA) and Howard Sandler (Michigan, USA); Springer UK; 2007-08; Reviewed in New England Journal of Medicine (05.06.2008; Volume 358:2527) p no. 2527; 23
  15. Book Editorship: Urological Oncology – Vinod H Nargund, Derek Raghavan and Howard Sandler; Springer UK; 2nd Edition in preparation. Expected date of Publication: December 2011
  16. Book Editorship: Urological Oncology for Nurses- Bruce Turner, Carol Cox Lawrence Drudge-Coates, Vinod Nargund. 2011 Springer
  17. Renal Cancer: MacMillan Booklet 2012